Researchers assessed coronary calcium score and cardiovascular monosodium urate deposits detected by dual-energy computed tomography in patients with gout vs healthy controls.
Researchers aimed to create a pharmacist-managed referral for the titration of urate-lowering therapy to target serum uric acid levels in patients with gout.
Researchers investigated the clinical features and risk factors for gout during tuberculosis treatment in a South Korean population.
Heart disease is associated with an increased risk for hospital admission for allopurinol-associated severe cutaneous adverse reactions.
Researchers investigated the association between exposure to urate-lowering drugs and the progression and recovery of chronic kidney disease in patients with gout.
Researchers investigated the effects of canagliflozin on serum urate levels and gout in patients with type 2 diabetes.
Four modifiable risk factors — body mass index (BMI), the Dietary Approaches to Stop Hypertension (DASH) diet, alcohol use, and diuretic use — could individually account for a notable proportion of hyperuricemia and possibly gout cases.
Investigators evaluated the quality and consistency of guidance documents for the treatment of gout and hyperuricemia.
Gout is associated with an elevated risk for chronic kidney disease (CKD) progression.
The study describes the variations of gout flares and assesses the different methods of gout flare reporting in clinical trials.